Inogen (INGN) Net Income Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Inogen | 165.85 Mn | 71.44 Mn | 37.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -62.62% |
| Dec 31, 2025 | -9.78% |
| Sep 30, 2025 | -25.52% |
| Jun 30, 2025 | -29.27% |
| Mar 31, 2025 | -31.19% |
| Dec 31, 2024 | -20.09% |
| Sep 30, 2024 | -23.46% |
| Jun 30, 2024 | -20.59% |
| Mar 31, 2024 | -36.56% |
| Dec 31, 2023 | -36.09% |
| Sep 30, 2023 | -36.75% |
| Jun 30, 2023 | -21.73% |
| Mar 31, 2023 | -31.23% |
| Dec 31, 2022 | 116.80% |
| Sep 30, 2022 | -26.94% |
| Jun 30, 2022 | -19.26% |
| Mar 31, 2022 | -34.47% |
| Dec 31, 2021 | -38.25% |
| Sep 30, 2021 | 18.34% |
| Jun 30, 2021 | -7.40% |
| Mar 31, 2021 | -18.03% |
| Dec 31, 2020 | -27.18% |
| Sep 30, 2020 | -21.34% |
| Jun 30, 2020 | -5.70% |
| Mar 31, 2020 | -24.66% |
| Dec 31, 2019 | -23.78% |
| Sep 30, 2019 | 26.33% |
| Jun 30, 2019 | 34.76% |
| Mar 31, 2019 | 42.96% |
| Dec 31, 2018 | -14.49% |
| Sep 30, 2018 | 84.24% |
| Jun 30, 2018 | 49.44% |
| Mar 31, 2018 | 71.27% |